2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosisMike P. Wattjes, Olga Ciccarelli, Daniel S. Reich et al.|The Lancet Neurology|2021Cited by 646
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Yael Hacohen et al.|The Lancet Neurology|2021Cited by 518
Diagnostic algorithm for relapsing acquired demyelinating syndromes in childrenYael Hacohen, Cheryl Hemingway, Kshitij Mankad et al.|Neurology|2017Cited by 192
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Treatment of MOG antibody associated disorders: results of an international survey.Daniel Whittam, A. Jacob, Eric C. Klawiter et al.|Research Padua Archive (University of Padua)|2020Cited by 139